找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hodgkin‘s and Non-Hodgkin‘s Lymphoma; John P. Leonard,Morton Coleman Book 2006 Springer-Verlag US 2006 Tumor.blood.bone.bone marrow.cell.d

[復制鏈接]
樓主: Awkward
21#
發(fā)表于 2025-3-25 03:41:01 | 只看該作者
22#
發(fā)表于 2025-3-25 10:48:44 | 只看該作者
Cancer Treatment and Researchhttp://image.papertrans.cn/h/image/427834.jpg
23#
發(fā)表于 2025-3-25 15:14:30 | 只看該作者
,Management of Advanced Stage Hodgkin’s Lymphoma,Hodgkin’s lymphoma (HL) is an uncommon malignancy of unknown etiology with an annual incidence in Western populations of 2–3 per 100,000 (.). On average there are 7000 new cases reported in the United States each year, distributed in a bimodal pattern with a first peak in the third decade and a second peak after the age of 50 (., .).
24#
發(fā)表于 2025-3-25 16:53:56 | 只看該作者
,Pathology of B-Cell Non-Hodgkin’s Lymphomas and Multiple Myeloma,L/SLL), appear to resemble more than one B-cell differentiation stage. Nevertheless, a basic understanding of B-cell differentiation stages and their associated immunophenotypic characteristics facilitates accurate diagnosis and appropriate management of B-NHLs.
25#
發(fā)表于 2025-3-25 21:11:38 | 只看該作者
Diffuse Large B-Cell NHL, play a role in the development of new prognostic models that may refine our ability to identify poor-risk patients. With this technology, over the next decade, it is hoped that novel therapeutic targets will be identified, allowing continued improvements in outcome for patients with this disease.
26#
發(fā)表于 2025-3-26 04:02:00 | 只看該作者
27#
發(fā)表于 2025-3-26 07:16:58 | 只看該作者
28#
發(fā)表于 2025-3-26 10:22:28 | 只看該作者
,Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma,of a series of differentiation antigens, termed “cluster of differentiation” (CD) antigens. These characteristics serve as the basis for the World Health Organization (WHO) Classification of Lymphoid Neoplasms [.]. These proteins are also valuable markers for diagnosing and classifying lymphomas, as well as reliable targets for therapy.
29#
發(fā)表于 2025-3-26 15:04:42 | 只看該作者
,Blood and Bone Marrow Transplantation for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma,) for patients with lymphoma. Initial studies were performed in refractory patients. These studies demonstrated the feasibility of this approach and ushered in more definitive trials in patients with homogenous histologies.
30#
發(fā)表于 2025-3-26 20:15:57 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 05:21
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
兴和县| 巴中市| 五莲县| 台前县| 苍梧县| 于田县| 南通市| 龙海市| 长治市| 彰化市| 独山县| 赣州市| 乐陵市| 东平县| 新平| 福贡县| 慈利县| 无锡市| 科尔| 建始县| 洮南市| 广汉市| 长海县| 象州县| 板桥市| 昭觉县| 兴文县| 洪泽县| 郯城县| 大冶市| 石景山区| 峨山| 信阳市| 左贡县| 福清市| 泽库县| 厦门市| 靖宇县| 株洲市| 柘荣县| 公安县|